Thanks Garce. I have been long on BMY since they were at $18, which has been a great and long ride. But the Plavix income is such a huge percentage of their business, that any reduction in sales/pricing is going to have a huge affect on their future earnings, at least in the relative near future until they can develop their pipeline.
I have to hand it to their directors and officers, they are glossing over the real news this year. They got burned bad today. All is not good that meets the eye.
So long. I'll get back in at $18 again in August or so. Till then, all the best. :)